New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 31, 2014
07:44 EDTIMAXIMAX recent weakness a buying opportunity, says JPMorgan
JPMorgan views the year-to-date pullback in shares of IMAX as a buying opportunity. The firm believes IMAX is performing well in China while the stock represents the best way to play the "promising" 2015 box office. JPMorgan keeps an Overweight rating on IMAX with a $32 price target.
News For IMAX From The Last 14 Days
Check below for free stories on IMAX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 25, 2014
10:02 EDTIMAXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:41 EDTIMAXIMAX upgraded to Buy from Hold at Benchmark Co.
Subscribe for More Information
07:33 EDTIMAXIMAX shares attractive at current levels, says JPMorgan
Subscribe for More Information
July 24, 2014
07:06 EDTIMAXIMAX reports theater network as of June 30 was 868 systems
Subscribe for More Information
07:05 EDTIMAXIMAX reports Q2 adjusted EPS 25c, consensus 21c
Subscribe for More Information
July 21, 2014
18:07 EDTIMAXIMAX adds 19 theaters throughout China with Shanghai Film Corp
IMAX announced an agreement with Shanghai Film Corporation and its subsidiaries for 19 IMAX theaters to be located in new construction projects throughout China. Nearly all of the 19 sites, which will be sales agreements, have been identified, with a significant number scheduled for installation before the end of 2015.
10:02 EDTIMAXOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:43 EDTIMAXIMAX upgraded to Buy from Hold at Stifel
Subscribe for More Information
July 16, 2014
10:00 EDTIMAXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:36 EDTIMAXIMAX downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use